This week the PRWeek Healthcare and Pharma Comms Awards took place to recognise and celebrate the most successful, dynamic figures and campaigns in the UK comms sector.
We’re absolutely delighted to share that our team’s work with HRA Pharma on Hello Hana – OTC Contraceptive Pill Launch was recognised in the Best Pharmaceutical Product Launch (OTC) category!
Access to contraception in the UK has been affected by budget cuts, fragmented services and reduced GP opening times, a situation that worsened during the pandemic. When HRA Pharma tasked us with the launch of Hana, the first contraceptive pill available over the counter (OTC), we jumped at the chance to be a part of this landmark in the history of women’s health.
Our meticulous approach to planning enabled us to deliver a bold campaign that generated over 740 balanced media stories, with the potential reach of over 15 billion and driving over 14,000 people to the Hana website.
Our client at HRA Pharma said, “At HRA, we firmly believe women should be able to take control of their contraceptive choice, and this key objective was reflected across the campaign, highlighting the significance of this ground-breaking launch. To further empower women, the campaign has continued to remove the stigma often associated with contraception and driven awareness of broader access to an effective option for many women.”
The PRWeek judges commented:
“Given this team was also competing with COVID for media attention, these results are truly impressive. In many ways this award entry feels like a best practice case study on good PR launch practice in healthcare. A careful, analytical approach to evidence generation, which underpinned the strategy, clearly yielded excellent results. Great metrics (including commercial outcomes). Overall the winner in my opinion.”
The launch was a historic moment for women’s health and we couldn’t be prouder.